Congenital hyperinsulinism caused by hexokinase I expression or glucokinase-activating mutation in a subset of β-cells. - Wikidata - awgldk - TriplyDB

Congenital hyperinsulinism caused by hexokinase I expression or glucokinase-activating mutation in a subset of β-cells.

Congenital hyperinsulinism caused by hexokinase I expression or glucokinase-activating mutation in a subset of β-cells.

http://www.wikidata.org/entity/Q40123629

about

Insights into the role of neuronal glucokinase Hyperinsulinemic Hypoglycemia - The Molecular Mechanisms Update on neonatal hypoglycemia.Raptor regulates functional maturation of murine beta cells.Congenital hyperinsulinism: current status and future perspectives.DNA methylation directs functional maturation of pancreatic β cells.Dynamics and Regulation of Insulin Secretion in Pancreatic Islets from Normal Young Children Perspective on the Genetics and Diagnosis of Congenital Hyperinsulinism Disorders Enhanced Islet Cell Nucleomegaly Defines Diffuse Congenital Hyperinsulinism in Infancy but Not Other Forms of the Disease Dominant form of congenital hyperinsulinism maps to HK1 region on 10q.Glucose control during labor and delivery.FFAR3 modulates insulin secretion and global gene expression in mouse islets.Hyperinsulinemic hypoglycemia: clinical, molecular and therapeutical novelties.New insights and new conundrums in neonatal hypoglycemia: enigmas wrapped in mystery.Congenital hyperinsulinism and Poland syndrome in association with 10p13-14 duplication.Formal Neurocognitive Testing in 60 Patients with Congenital Hyperinsulinism.Congenital Hyperinsulinism: Diagnosis and Treatment Update.Pharmacological approach to understanding the control of insulin secretion in human islets.Atypical Forms of Congenital Hyperinsulinism in Infancy Are Associated With Mosaic Patterns of Immature Islet Cells.Focal congenital hyperinsulinism managed by medical treatment: a diagnostic algorithm based on molecular genetic screening.Congenital hyperinsulinism: global and Japanese perspectives.

P2860

Q26748833-1FD1FF0F-6959-4529-B6A4-76F0A8E31F13 Q26749617-D077BB7E-0B0A-46E3-AAA5-D0CF3189B55C Q33575385-3CEFBD9F-31AC-4705-9A5F-F8C2438C93A3 Q33804727-6A8CD7D5-07AC-4DE2-B000-C50496A7A7EE Q33964788-B5073EF3-139F-4EDA-B1E0-5A41E6E398AA Q36040239-47F47BEE-5AD9-4E10-AAF0-2AD784687401 Q36180400-1DE2A23A-F6AF-4485-9BCD-7E2F782E304D Q36716020-14450340-FAF0-4BC0-B901-EC6F6A897A9A Q37041702-94BBA90D-82B1-4FB6-A461-9DB9AF070BD7 Q37422505-042C19A3-AB2D-45D5-92CB-B6C0D41072F2 Q38167663-DE31B987-1EFC-4A11-A5F7-EE323A7D2064 Q38993851-6340FC16-05BE-492B-ABBB-216BD6781BE8 Q39401763-137B9097-253E-4516-A582-76B1B48B2BDC Q40123978-75658EC7-97E7-4313-BC88-54304C79886A Q42030143-5A13BEC5-3FBB-4DDF-8B2F-CFF68FD8FF4A Q47609331-D152E1C6-8FBA-4957-B23E-B6FD3A779BFC Q47894084-A255EB61-9CB1-4483-B52C-DA3118B97813 Q48318446-7F0817DD-963B-46C0-A7EA-05A471CCC1C2 Q50948908-C22C52EF-9FBE-4963-9D78-F1BB01D871C0 Q51127204-8D28E79B-2377-4A6A-8167-42FA53C6A4C5 Q51261501-CAC74CC5-DCAE-4107-8C46-5B50312DFA2C

P2860

Congenital hyperinsulinism caused by hexokinase I expression or glucokinase-activating mutation in a subset of β-cells.

http://www.wikidata.org/entity/Q40123629

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Congenital hyperinsulinism cau ...... tation in a subset of β-cells.

@en

type

label

Congenital hyperinsulinism cau ...... tation in a subset of β-cells.

@en

prefLabel

Congenital hyperinsulinism cau ...... tation in a subset of β-cells.

@en

P1433

Q40123629-6FAAFCC4-E8D6-4F35-A0C5-CB6F0E02155A

P1476

Q40123629-0170EB36-2EB2-491B-8F10-4A8AE56FA556

P2093

Q40123629-4203A3AE-4A90-4EC1-9BAA-CA273DCC935C

Q40123629-50AFB58D-9CBF-4099-94A9-BD926A7404C6

Q40123629-9E8ABEBD-57FF-4A9A-9CF8-FE97E45867E0

Q40123629-A749A05A-976D-4401-96C1-F3969A986F35

Q40123629-C653464A-5A17-4685-9F59-6089DF707C8E

Q40123629-D0ED5CFF-B3C8-43EC-A5F9-40ED1C742912

P2860

Q40123629-0597E740-94C5-47B8-9514-5E866454F10E

Q40123629-09A35E6C-9FA2-4E33-86F7-22330BA160BB

Q40123629-09FE2772-E6E1-4D07-80A3-D73AAE9C34C1

Q40123629-0D8942F4-BD54-4EE7-BD08-2BA19462A049

Q40123629-128FB428-A3A7-4CBE-BA72-6B46FAF9F01F

Q40123629-14F9D6C2-0994-43C1-8838-41A37FA023CA

Q40123629-1A18F5D4-435E-4CB0-B2C4-A488D814F62C

Q40123629-267720C0-B38C-4268-B209-C57EF4FC87B5

Q40123629-27B0FCF7-81EA-4BC6-98CE-4FA285E2017D

Q40123629-2AD72D6F-837A-49B1-B328-31188037AC21

P304

Q40123629-AEF8C333-F32B-416C-9E6C-F0473CE100AD

P31

Q40123629-6279EECA-2ED7-42CD-AE8F-4A3D24504548

P356

Q40123629-5003F0AA-841E-40D6-9330-D75662560DB9

P407

Q40123629-334615F3-8056-498E-B0E6-F0CF29E16294

P433

Q40123629-EE1263A1-E9D2-40F9-801E-DB724E595087

P478

Q40123629-D0FF3E6C-1D02-4EEE-949F-7AC51FBCEFA3

P50

Q40123629-E5BEB33E-FB3E-44C3-BA10-A792BA2D512C

P577

Q40123629-7129DE64-0733-4243-99C8-D92780DE9D60

P5875

Q40123629-792EA239-B75A-4E02-BCAA-10F5DB699CC5

P698

Q40123629-675D64B1-3AAB-44D3-A34D-5E7E146CD6C0

P921

Q40123629-3680183B-9E2D-4A31-BF82-156D441293E0

P932

Q40123629-22A9B2B8-FEEE-4306-A1CE-1D53CA54C2F9

P356

P1433

P1476

Congenital hyperinsulinism cau ...... tation in a subset of β-cells.

@en

P2093

Jacques Rahier

http://www.w3.org/2001/XMLSchema#string

Jean-Claude Henquin

http://www.w3.org/2001/XMLSchema#string

Joelle Marchandise

http://www.w3.org/2001/XMLSchema#string

Myriam Nenquin

http://www.w3.org/2001/XMLSchema#string

Sebastien Godecharles

http://www.w3.org/2001/XMLSchema#string

Yves Guiot

http://www.w3.org/2001/XMLSchema#string

P2860

Insights into the biochemical and genetic basis of glucokinase activation from naturally occurring hypoglycemia mutations

Mutation of the pancreatic islet inward rectifier Kir6.2 also leads to familial persistent hyperinsulinemic hypoglycemia of infancy

Clinical characteristics and biochemical mechanisms of congenital hyperinsulinism associated with dominant KATP channel mutations.

Human and rat beta cells differ in glucose transporter but not in glucokinase gene expression

Molecular biology of adenosine triphosphate-sensitive potassium channels

Physical exercise-induced hypoglycemia caused by failed silencing of monocarboxylate transporter 1 in pancreatic beta cells

Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene

Tissue-specific deletion of Foxa2 in pancreatic beta cells results in hyperinsulinemic hypoglycemia

Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion

Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene

P304

1689-1696

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DB12-1414

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

62

http://www.w3.org/2001/XMLSchema#string

P50

Christine Sempoux

P577

2012-12-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

234011554

http://www.w3.org/2001/XMLSchema#string

P698

23274908

http://www.w3.org/2001/XMLSchema#string

P921

P932

3636634

http://www.w3.org/2001/XMLSchema#string